LAG3 and lung cancer: T‐cell immunoglobulin and mucin‐domain containing 3 (TIM‐3), lymphocyte‐activation gene 3 (LAG‐3), and programmed cell death 1 (PD‐1) showed differential functional impact, tissue/cell distribution, and clinical significance in nonsmall cell lung cancer.